Werewolf Therapeutics, Inc. (HOWL)
Develops immune-boosting cancer drugs that activate only when they find tumor cells.
$0.45-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-61.3%
The outlook
HOWL trades near its 52-week low at $0.45, with a mixed technical picture relative to its moving averages. Analyst coverage shows a striking disconnect: the average price target sits roughly 1,458% above the current price, yet the overall sentiment leans bearish. This divergence suggests elevated uncertainty about the company's near-term prospects despite optimistic long-term views.
What’s behind the score
Price trendMixed vs its moving averages
52-week range8% of the way from its 52-week low to high
Price targetAvg target +1458% vs current price
Market cap
$21.8M
52-wk high
$2.38
52-wk low
$0.27
50-day avg
$0.39
200-day avg
$0.77
Trailing P/E
—